Lymphedema Treatment Act of 2019

Issues relating to Medicares coverage of lymphedema treatment and the Lymphedema Treatment Act (S. 518/H.R. 1948). H.R. 8337 - Continuing Appropriations Act, 2021 and Other Extensions Act H.R. 133 - Consolidated Appropriations Act, 2021

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Prevention Initiatives for Fraud and Abuse in the Medicare program NCCI Edits Protection of programs related to physical therapy in deficit reduction Medicare Advantage Essential Health Benefits Medicare improvement standards Medicare appeals process Inclusion of physical therapists in quality programs Medicare Self-referral Coverage of telehealth APTA PT Outcomes Registry/Qualified Clinical Data Registries Medicare Quality Programs Accelerating Innovation in Medicine Act (AIM) IMPACT Act Chronic Care Management Orthotics and Prosthetics Medicare Private Contracting SNF 3-Day rule Administrative Burden PTA Differential in Medicare Prior Authorization in Medicare Advantage Plans Alternative payment models Health information technology: Electronic health records, health IT incentives for physical therapists, certification of EHRs interoperability, and information blocking DMEPOS competitive bidding Medicare enrollment Skilled Nursing Facility payment Home Health payment Medical review (Medicare) Technical expert panel nominations Reducing Health Care costs REAADI & DRMA Acts S. 433 Home Health Payment Innovation Act HR 3107 Improving Seniors Timely Access to Care Act of 2019 HR 1948/S. 518 Lymphedema Treatment Act of 2019 Improving Access to Medicare Coverage Act of 2019 (HR 7682/S 753) Critical Access Hospital Relief Act of 2019 (HR 1041/S 586) Medicare Opt-Out HR 4932/S 2741 CONNECT for Health Act of 2019 Medicare Fee Schedule HR 5693 Primary Health Services Enhancement Act Unified post-acute care prospective payment system Medicare Accelerated and Advanced Payments Program

Client expense: $236,490 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Social Security Administration (SSA), Veterans Affairs, Dept of (VA), White House Office

Monitoring healthcare regulations and legislation; Palliative Care Hospice Education & Treatment Act PCHETA (H.R 647/S 2080); Cancer Drug Parity Act (H.R. 1730/S. 741); Lymphedema Treatment Act (H.R. 1948/S. 518); Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act" (H.R.2111/S.1048; Title VIII funding

Client expense: $54,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, White House Office

Legislative advocacy for the inclusion of compression treatment equipment as covered items under the Medicare Program; HR.1948 and S.518 the Lymphedema Treatment Act.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 518/H.R. 1948 - Lymphedema Treatment Act of 2019 S. 1037/H.R. 2788 - Rural Health Clinic Modernization Act of 2019 S. 296/H.R. 2150 - Home Health Care Planning Improvement Act S. 237/H.R. 808 - Promoting Access to Diabetic Shoes Act H.R. 900 - ACO Assignment Improvement Act of 2019 S. 1399/H.R. 728 - Title VIII Nursing Workforce Reauthorization Act of 2019 S. 2842/H.R. 3911 - Increasing Access to Quality Cardiac Rehabilitation Care Act of 2019 S. 1895 - Lower Health Care Costs Act H.R. 3107 - Improving Seniors' Timely Access to Care Act of 2019 H.R. 3630 - No Surprises Act H.R. 3925 - Reducing Barriers to Substance Use Treatment Act S.2074/H.R. 2482 - Mainstreaming Addiction Treatment Act of 2019 H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act H.R. 4974/S. 4640 - Medication Access and Training Expansion (MATE) Act of 2019 Executive Order 13890 - Protecting and Improving Medicare for Our Nation's Seniors S. 2741/H.R. 4932 - Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019 S. 2971 - CAPTA Reauthorization Act of 2019 H.R. 19 - Lower Costs, More Cures Act of 2019 S. 2543 - Prescription Drug Pricing Reduction Act of 2019 H.R. 647 - Palliative Care and Hospice Education and Training Act H.R. 748 (P.L. 116-136) - CARES Act S. 3548 - CARES Act H.R. 6201 - Families First Coronavirus Response Act H.R. 6704 - Coronavirus Preparedness and Response Supplemental Appropriations Act H.R. 6379 - Take Responsibility for Workers and Families Act H.R. 6159 - Kids' Access to Primary Care Act of 2020 H.R. 6164 - Perinatal Workforce Act of 2020 H.R. 5826 - Consumer Protections Against Surprise Medical Bills Act of 2020 H.R. 5800 - Ban Surprise Billing Act H.R. 3436 - Chronic Care Management Improvement Act H.R. 5575 - Primary and Behavioral Health Care Access Act S. Res. 500/H. Res. 859 - A resolution supporting the goals and ideals of the "International Year of the Nurse and the Midwife", as designated by the World Health Organization H.R. 6800 - The HEROES Act H.R. 6809 - Nurse Workforce Protection Act of 2020 H.R. 6650/S. 3634 - Health Heroes 2020 Act S. 4055 - Strengthening Americas Health Care Readiness Act H.R. 266 - Paycheck Protection Program and Health Care Enhancement Act S. 3993 - A bill to permit a licensed health care provider to provide health care services to individuals in one or more States in which the provider is not licensed S. 4088 - The Ensuring Access to Primary Care for Women & Children Act H.R. 1329 - the Medicaid Reentry Act H.R. 8061 - Community Immunity During COVID-19 Act H.R. 925 - The Heroes Act The Health, Economic Assistance, Liability Protections & Schools (HEALS) Act S.4775 - Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act S. 4103 - Telehealth Response for E-prescribing Addiction Therapy Services (TREATS) Act H.R. 7663 - Protecting Access to Post-COVID-19 Telehealth Act of 2020 S. 4396/H.R. 7945 - Future Advancement of Academic Nursing (FAAN) Act Increased Federal Medical Assistance Percentage (FMAP) funding to states Skilled nursing facility admitting examination and assessment requirements COVID-19 Pandemic relief: funding, removal of barriers, telehealth, mental health, personal protective equipment, and testing Telehealth pertaining to home health care COVID-19 Pandemic Reducing Regulatory Burdens, including those relating to home infusion therapy, Medicare Conditions of Participation, and hospice certification Medication-Assisted Therapies (MATs) Opioid Abuse Epidemic Documentation of medical records Rural Health Issues Provider Non-Discrimination Issues relating to Mental and Substance Use Disorder Workforce Training Demonstration implementation

Client expense: $191,402 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Veterans Affairs, Dept of (VA), White House Office

Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or The HEROES Act HR 1948, Lymphedema Treatment Act; HR 1570 and S. 668, the Removing Barriers to Colorectal Cancer Screening Act, and regulatory issues related to the Medicare coinsurance issue in these bills; HR 913, The CLINICAL TREATMENT Act, Medicaid covering routine care costs for beneficiaries who participate in an approved clinical trials; Senate introduction (no bill number just yet); Issues related to Medicaid Non-Emergency Medical Transportation; and Issues related to Chimeric antigen receptor (CAR) T-cell therapy and reimbursement. HR 2477, Beneficiary Enrollment Notification and Eligibility Simplification Act (BENES) Regulatory issues related to Medicaid and value-based payment HR 7663, Protecting Access to Post COVID 19 Telehealth Act of 2020

Client expense: $815,440 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office

No bill: Support inclusion of occupational therapy services via telehealth under Medicare Part B, Medicare Advantage and any demonstration programs such as telehealth within accountable care organizations. HR 3127/S 1725 - The Home Health Flexibility Act: Support the ability of occupational therapists to conduct the initial and comprehensive assessments for Medicare Home Health cases. S 518/HR 1948 - Lymphedema Treatment Act - Support passage. No bill: Advocate for Congressional oversight of new Medicare payment models - PDPM & PDGM. No bill: Support for Congressional attention to the issue of falls related injuries and falls prevention. No bill: Advocated to stop proposed cuts to therapy services in the 2021 Physician Fee Schedule. HR 4932/S 2741 - CONNECT for Health Act of 2019: Support expanded coverage for services provided to Medicare patients via telehealth, including occupational therapy and other therapy services. HR 1329 - Medicaid Reentry Act (mental health and Medicaid policy): Support passage S 1754/HR 3215 - The Disaster Relief Medicaid Act (DRMA): Support passage No bill: Support for Medicare payment for evidence-based programs, led by occupational therapists, that support caregivers for people with dementia. No bill: Support for Medicare payment for evidence-based programs, led by occupational therapists, to support aging in place. S 1202 - Independence At Home Act: support passage HR2408 - Ensuring Access to Complex Rehabilitation Technology Act of 2019: support passage HR 748, CARES Act: Advocated to include occupational therapy practitioners as eligible Medicare telehealth service providers for both the duration of the COVID-19 public health emergency and on a permanent basis. HR 7154 - Outpatient Therapy Modernization and Stabilization Act: Support passage. HR 6634 - Emergency COVID Telehealth Response Act: Support introduction and passage. No bill #: Support for waiving statutory budget neutrality requirements, or exempting certain provider specialties from the application of budget neutrality, for the implementation of new Evaluation and Management Codes in the 2021 Medicare Physician Fee Schedule, and inclusion of this waiver in any COVID-19 legislation. HR 6365/3559 -Immediate Relief for Rural Facilities and Providers Act of 2020: Support passage. CMS - Met with CMS to discuss Medicare Part B payment reductions to therapy provider payments proposed in the 2021 physician fee schedule: Participants included Demetrios Kouzoukas, Director of Medicare. S. 4375 - Telehealth Modernization Act: Support , particularly for provisions that would allow the Secretary of Health and Human Services to permanently add occupational therapy practitioners to the Medicare telehealth benefit. Support various House and Senate proposals to extend and make permanent the Public Health Emergency provisions that enable occupational therapists to provide services to Medicare patients via telehealth.

Client expense: $130,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Prevention Initiatives for Fraud and Abuse in the Medicare program NCCI Edits Protection of programs related to physical therapy in deficit reduction Medicare Advantage Essential Health Benefits Medicare improvement standards Medicare appeals process Inclusion of physical therapists in quality programs Medicare Self-referral Coverage of telehealth APTA PT Outcomes Registry/Qualified Clinical Data Registries Medicare Quality Programs Accelerating Innovation in Medicine Act (AIM) IMPACT Act Chronic Care Management Orthotics and Prosthetics Medicare Private Contracting SNF 3-Day rule Administrative Burden PTA Differential in Medicare Prior Authorization in Medicare Advantage Plans Alternative payment models Health information technology: Electronic health records, health IT incentives for physical therapists, certification of EHRs interoperability, and information blocking DMEPOS competitive bidding Medicare enrollment Skilled Nursing Facility payment Home Health payment Medical review (Medicare) Technical expert panel nominations Reducing Health Care costs REAADI & DRMA Acts S. 433 Home Health Payment Innovation Act HR 3107 Improving Seniors Timely Access to Care Act of 2019 HR 1948/S. 518 Lymphedema Treatment Act of 2019 Improving Access to Medicare Coverage Act of 2019 (HR 7682/S 753) Critical Access Hospital Relief Act of 2019 (HR 1041/S 586) Medicare Opt-Out HR 4932/S 2741 CONNECT for Health Act of 2019 Medicare Fee Schedule HR 5693 Primary Health Services Enhancement Act Unified post-acute care prospective payment system Medicare Accelerated and Advanced Payments Program

Client expense: $236,490 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Social Security Administration (SSA), Veterans Affairs, Dept of (VA), White House Office

Issues relating to Medicares coverage of lymphedema treatment and the Lymphedema Treatment Act (S. 518/H.R. 1948). H.R. 6800 - The Heroes Act H.R. 8337 - Continuing Appropriations Act, 2021 and Other Extensions Act H.R. 925 - The HEROES Act

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues relating to Medicares coverage of lymphedema treatment and the Lymphedema Treatment Act (S. 518/H.R. 1948). H.R. 6800 - The Heroes Act H.R. 8337 - Continuing Appropriations Act, 2021 and Other Extensions Act H.R. 925 - The HEROES Act

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 518/H.R. 1948 - Lymphedema Treatment Act of 2019 S. 1037/H.R. 2788 - Rural Health Clinic Modernization Act of 2019 S. 296/H.R. 2150 - Home Health Care Planning Improvement Act S. 237/H.R. 808 - Promoting Access to Diabetic Shoes Act H.R. 900 - ACO Assignment Improvement Act of 2019 S. 1399/H.R. 728 - Title VIII Nursing Workforce Reauthorization Act of 2019 S. 2842/H.R. 3911 - Increasing Access to Quality Cardiac Rehabilitation Care Act of 2019 S. 1895 - Lower Health Care Costs Act H.R. 3107 - Improving Seniors' Timely Access to Care Act of 2019 H.R. 3630 - No Surprises Act H.R. 3925 - Reducing Barriers to Substance Use Treatment Act S.2074/H.R. 2482 - Mainstreaming Addiction Treatment Act of 2019 H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act H.R. 4974 - Medication Access and Training Expansion Act of 2019 Executive Order 13890 - Protecting and Improving Medicare for Our Nation's Seniors S. 2741/H.R. 4932 - Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019 S. 2971 - CAPTA Reauthorization Act of 2019 H.R. 19 - Lower Costs, More Cures Act of 2019 S. 2543 - Prescription Drug Pricing Reduction Act of 2019 H.R. 647 - Palliative Care and Hospice Education and Training Act H.R. 748 (P.L. 116-136) - CARES Act S. 3548 - CARES Act H.R. 6201 - Families First Coronavirus Response Act H.R. 6704 - Coronavirus Preparedness and Response Supplemental Appropriations Act H.R. 6379 - Take Responsibility for Workers and Families Act H.R. 6159 - Kids' Access to Primary Care Act of 2020 H.R. 6164 - Perinatal Workforce Act of 2020 H.R. 5826 - Consumer Protections Against Surprise Medical Bills Act of 2020 H.R. 5800 - Ban Surprise Billing Act H.R. 3436 - Chronic Care Management Improvement Act H.R. 5575 - Primary and Behavioral Health Care Access Act S. Res. 500/H. Res. 859 - A resolution supporting the goals and ideals of the "International Year of the Nurse and the Midwife", as designated by the World Health Organization H.R. 6800 - The HEROES Act H.R. 6809 - Nurse Workforce Protection Act of 2020 H.R. 6650/S. 3634 - Health Heroes 2020 Act S. 4055 - A bill to address health workforce shortages and disparities highlighted by the COVID-19 pandemic through additional funding for the National Health Service Corps and the Nurse Corps, and to establish a National Health Service Corps Emergency Service demonstration project H.R. 266 - Paycheck Protection Program and Health Care Enhancement Act S. 3993 - A bill to permit a licensed health care provider to provide health care services to individuals in one or more States in which the provider is not licensed S. 4088 - The Ensuring Access to Primary Care for Women & Children Act H.R. 1329 - the Medicaid Reentry Act Increased Federal Medical Assistance Percentage (FMAP) funding to states Skilled nursing facility admitting examination and assessment requirements COVID-19 Pandemic relief: funding, removal of barriers, telehealth, mental health, personal protective equipment, and testing Telehealth pertaining to home health care COVID-19 Pandemic Reducing Regulatory Burdens, including those relating to home infusion therapy, Medicare Conditions of Participation, and hospice certification Medication-Assisted Therapies (MATs) Opioid Abuse Epidemic Documentation of medical records Rural Health Issues Provider Non-Discrimination Issues relating to Mental and Substance Use Disorder Workforce Training Demonstration implementation

Client expense: $194,712 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Veterans Affairs, Dept of (VA), White House Office

No bill: Support inclusion of occupational therapy services via telehealth under Medicare Part B, Medicare Advantage and any demonstration programs such as telehealth within accountable care organizations. HR 3127/S 1725 - The Home Health Flexibility Act: Support the ability of occupational therapists to conduct the initial and comprehensive assessments for Medicare Home Health cases. S 518/HR 1948 - Lymphedema Treatment Act - Support passage. No bill: Advocate for Congressional oversight of new Medicare payment models - PDPM & PDGM. No bill: Support for Congressional attention to the issue of falls related injuries and falls prevention. No bill: Advocated to stop proposed cuts to therapy services in the 2021 Physician Fee Schedule. HR 4932/S 2741 - CONNECT for Health Act of 2019: Support expanded coverage for services provided to Medicare patients via telehealth, including occupational therapy and other therapy services. HR 1329 - Medicaid Reentry Act (mental health and Medicaid policy): Support passage S 1754/HR 3215 - The Disaster Relief Medicaid Act (DRMA): Support passage No bill: Support for Medicare payment for evidence-based programs, led by occupational therapists, that support caregivers for people with dementia. No bill: Support for Medicare payment for evidence-based programs, led by occupational therapists, to support aging in place. S 1202 - Independence At Home Act: support passage HR2408 - Ensuring Access to Complex Rehabilitation Technology Act of 2019: support passage HR 748, CARES Act: Advocated to include occupational therapy practitioners as eligible Medicare telehealth service providers for both the duration of the COVID-19 public health emergency and on a permanent basis. HR 7154 - Outpatient Therapy Modernization and Stabilization Act: Support introduction and passage. HR 6634 - Emergency COVID Telehealth Response Act: Support introduction and passage. No bill #: Support for waiving statutory budget neutrality requirements, or exempting certain provider specialties from the application of budget neutrality, for the implementation of new Evaluation and Management Codes in the 2021 Medicare Physician Fee Schedule, and inclusion of this waiver in any COVID-19 legislation. HR 6365/3559 -Immediate Relief for Rural Facilities and Providers Act of 2020: Support passage. Meeting with CMS officials from Division of Non-Institutional Quality Standards both Mary Rossi-Coajou, Senior Nurse Consultant and Maria Hammel, Director; from Division of Continuing and Acute Care Providers both James Cowher, Branch Manager and Tara Lemons, RDN,RN,MA,MSN; and from Division of Home Health, Hospice and HCPCS Kelly Vontran, Acting Deputy Director: Advocated making permanent the public health emergency provisions that enable occupational therapists to open Medicare home health therapy cases. CMS - Met with Demetrios Kouzoukas, Director of Medicare, Ing-Jyu Cheng, Acting Director of Hospital and Ambulatory Policy Group, and Gift Tee, Director of the Division of Practitioner Services: Discussed Medicare Part B payment reductions to therapy provider payments proposed for the 2021 physician fee schedule in 84 FR 62568. GAO - Met with officials from the Office of Management and Budget and official from the Office of Information and Regulatory Affairs: Discussed Medicare Part B payment reductions to therapy provider payments proposed for the 2021 physician fee schedule in 84 FR 62568

Client expense: $220,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, SENATE

Monitoring healthcare regulations and legislation; Palliative Care Hospice Education & Treatment Act PCHETA (H.R 647/S 2080); Cancer Drug Parity Act (H.R. 1730/S. 741); Lymphedema Treatment Act (H.R. 1948/S. 518); Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act" (H.R.2111/S.1048; Title VIII funding

Client expense: $90,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, White House Office

Legislative advocacy for the inclusion of compression treatment equipment as covered items under the Medicare Program; HR.1948 and S.518 the Lymphedema Treatment Act.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or The HEROES Act HR 3436, Chronic Care Management Improvement Act HR 1948, Lymphedema Treatment Act; HR 6808, Patient Navigation Assistance Act; HR 1570 and S. 668, the Removing Barriers to Colorectal Cancer Screening Act, and regulatory issues related to the Medicare coinsurance issue in these bills; HR 913, The CLINICAL TREATMENT Act, Medicaid covering routine care costs for beneficiaries who participate in an approved clinical trials; Issues related to Medicaid Non-Emergency Medical Transportation; and Issues related to Chimeric antigen receptor (CAR) T-cell therapy and reimbursement.

Client expense: $710,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office

Issues relating to Medicare's coverage of lymphedema treatment and the Lymphedema Treatment Act (S. 518/H.R. 1948). H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act H.R. 6201 - Families First Coronavirus Response Act H.R. 748 - Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 6800 - Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues relating to Medicare's coverage of lymphedema treatment and the Lymphedema Treatment Act (S. 518/H.R. 1948). H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act H.R. 6201 - Families First Coronavirus Response Act H.R. 748 - Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 6800 - Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Prevention Initiatives for Fraud and Abuse in the Medicare program Electronic health records/health information technology incentives for Physical Therapists NCCI Edits Protection of programs related to physical therapy in deficit reduction Medicare Advantage Health Information Technology Essential Health Benefits Medicare improvement standards Medicare appeals process Inclusion of physical therapists in quality programs Medicare Self-referral Coverage of telehealth APTA Registry/QCDR measures Medicare Quality Programs Accelerating Innovation in Medicine Act (AIM) IMPACT Act Chronic Care Management Orthotics and Prosthetics Medicare Private Contracting SNF 3-Day rule PT Outcomes Registry Administrative Burden PTA Differential in Medicare Prior Authorization in Medicare Advantage Plans Alternative payment models Certified EHR technology DMEPOS competitive bidding Medicare enrollment Skilled Nursing Facility payment Home Health payment Medical review (Medicare) Technical expert panel nominations Reducing Health Care costs REAADI & DRMA Acts S. 433 Home Health Payment Innovation Act HR 3107 Improving Seniors Timely Access to Care Act of 2019 HR 1948/S. 518 Lymphedema Treatment Act of 2019 Improving Access to Medicare Coverage Act of 2019 (HR 7682/S 753) Critical Access Hospital Relief Act of 2019 (HR 1041/S 586) Medicare Opt-Out HR 4932/S 2741 CONNECT for Health Act of 2019 Medicare Fee Schedule HR 5693 Primary Health Services Enhancement Act

Client expense: $236,490 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Social Security Administration (SSA), Veterans Affairs, Dept of (VA), White House Office

Prevention Initiatives for Fraud and Abuse in the Medicare program Electronic health records/health information technology incentives for Physical Therapists NCCI Edits Protection of programs related to physical therapy in deficit reduction Medicare Advantage Health Information Technology Essential Health Benefits Medicare improvement standards Medicare appeals process Inclusion of physical therapists in quality programs Medicare Self-referral Coverage of telehealth APTA Registry/QCDR measures Medicare Quality Programs Accelerating Innovation in Medicine Act (AIM) IMPACT Act Chronic Care Management Orthotics and Prosthetics Medicare Private Contracting SNF 3-Day rule PT Outcomes Registry Administrative Burden PTA Differential in Medicare Prior Authorization in Medicare Advantage Plans Alternative payment models Certified EHR technology DMEPOS competitive bidding Medicare enrollment Skilled Nursing Facility payment Home Health payment Medical review (Medicare) Technical expert panel nominations Reducing Health Care costs REAADI & DRMA Acts S. 433 Home Health Payment Innovation Act of 2019 HR 3107 Improving Seniors Timely Access to Care Act of 2019 HR 1948/S. 518 Lymphedema Treatment Act of 2019 Improving Access to Medicare Coverage Act of 2019 (HR 7682/S 753) Critical Access Hospital Relief Act of 2019 (HR 1041/S 586) Medicare Opt-Out Home Health Payment Innovation Act (S 433) HR 4932/S 2741 CONNECT for Health Act of 2019 Medicare Fee Schedule HR 5693 Primary Health Services Enhancement Act

Client expense: $236,490 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Social Security Administration (SSA), Veterans Affairs, Dept of (VA), White House Office

S.518/H.R.1948, Lymphedema Treatment Act

Client expense: $1,010,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Highway Traffic Safety Administration (NHTSA), Patent & Trademark Office (PTO), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

S.518 / H.R.1948, Lymphedema Treatment Act S. 1895, Lower Health Care Costs Act

Client expense: $1,010,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Highway Traffic Safety Administration (NHTSA), Patent & Trademark Office (PTO), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

S. 518/H.R. 1948 - Lymphedema Treatment Act of 2019 S. 1037/H.R. 2788 - Rural Health Clinic Modernization Act of 2019 S. 296/H.R. 2150 - Home Health Care Planning Improvement Act S. 237/H.R. 808 - Promoting Access to Diabetic Shoes Act H.R. 900 - ACO Assignment Improvement Act of 2019 S. 1399/H.R. 728 - Title VIII Nursing Workforce Reauthorization Act of 2019 S. 2842/H.R. 3911 - Increasing Access to Quality Cardiac Rehabilitation Care Act of 2019 S. 1895 - Lower Health Care Costs Act H.R. 3107 - Improving Seniors' Timely Access to Care Act of 2019 H.R. 3630 - No Surprises Act H.R. 3925 - Reducing Barriers to Substance Use Treatment Act S.2074/H.R. 2482 - Mainstreaming Addiction Treatment Act of 2019 H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act H.R. 4974 - Medication Access and Training Expansion Act of 2019 Executive Order 13890 - Protecting and Improving Medicare for Our Nation's Seniors S. 2741/H.R. 4932 - Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019 S. 2971 - CAPTA Reauthorization Act of 2019 H.R. 19 - Lower Costs, More Cures Act of 2019 S. 2543 - Prescription Drug Pricing Reduction Act of 2019 H.R. 647 - Palliative Care and Hospice Education and Training Act H.R. 748 (P.L. 116-136): CARES Act S. 3548: CARES Act H.R. 6201: Families First Coronavirus Response Act H.R. 6704: Coronavirus Preparedness and Response Supplemental Appropriations Act H.R. 6379: Take Responsibility for Workers and Families Act H.R. 6159: Kids' Access to Primary Care Act of 2020 H.R. 6164: Perinatal Workforce Act of 2020 H.R. 5826: Consumer Protections Against Surprise Medical Bills Act of 2020 H.R. 5800: Ban Surprise Billing Act H.R. 3436: Chronic Care Management Improvement Act H.R. 5575: Primary and Behavioral Health Care Access Act S.Res. 500/H.Res. 859: A resolution supporting the goals and ideals of the "International Year of the Nurse and the Midwife", as designated by the World Health Organization COVID-19 Pandemic Reducing Regulatory Burdens, including those relating to home infusion therapy, Medicare Conditions of Participation, and hospice certification Medication-Assisted Therapies (MATs) Opioid Abuse Epidemic Documentation of medical records Rural Health Issues Provider Non-Discrimination

Client expense: $195,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Veterans Affairs, Dept of (VA), White House Office

Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 6201, Families First Coronavirus Response Act (Medicaid and Medicare provisions) HR 6704, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (Medicaid and Medicare provisions) H.R. 748 Coronavirus Aid, Relief, and Economic Security Act HR 1948, Lymphedema Treatment Act; HR 6808, Patient Navigation Assistance Act; HR 1570 and S. 668, the Removing Barriers to Colorectal Cancer Screening Act, and regulatory issues related to the Medicare coinsurance issue in these bills; CMS-issued regulations pertaining to Medicare Part B reimbursement - the CY2020 Medicare Physician Fee Schedule; HR 913, The CLINICAL TREATMENT Act, Medicaid covering routine care costs for beneficiaries who participate in an approved clinical trial; The Healthy Adult Opportunity guidance from CMS on allowing states to block grant their Medicaid programs Issues related to Medicaid Non-Emergency Medical Transportation; and S. 2911 - Seniors Prescription Drug Relief Act of 2019, would allow Medicare beneficiaries who reach an out of pocket cap to spread their payments over the course of the entire year; and Issues related to Chimeric antigen receptor (CAR) T-cell therapy and reimbursement.

Client expense: $730,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office

No bill: Support inclusion of occupational therapy services via telehealth under Medicare Part B, Medicare Advantage and any demonstration programs such as telehealth within accountable care organizations. HR 3127/S 1725 - The Home Health Flexibility Act: Support the ability of occupational therapists to conduct the initial and comprehensive assessments for Medicare Home Health cases. S 518/HR 1948 - Lymphedema Treatment Act - Support passage. No bill: Advocate for Congressional oversight of new Medicare payment models - PDPM & PDGM. No bill: Support for Congressional attention to the issue of falls related injuries and falls prevention. No bill: Advocated to stop proposed cuts to therapy services in the 2021 Physician Fee Schedule. HR 4932/S 2741 - CONNECT for Health Act of 2019: Support expanded coverage for services provided to Medicare patients via telehealth, including occupational therapy and other therapy services. HR 1329 - Medicaid Reentry Act (mental health and Medicaid policy): Support passage S 1754/HR 3215 - The Disaster Relief Medicaid Act (DRMA): Support passage No bill: Support for Medicare payment for evidence-based programs, led by occupational therapists, that support caregivers for people with dementia. No bill: Support for Medicare payment for evidence-based programs, led by occupational therapists, to support aging in place. HR 1109 - Mental Health Services for Students Act: Support passage HR 4564 - Suicide Prevention Lifeline Improvement Act: Support passage HR 1767 - Excellence in Mental Health and Addiction Treatment Expansion Act: Support passage HR 4861 - Effective Suicide Screening and Assessment in the Emergency Department Act: Support passage HR 4309 - Barriers to Suicide Act: Support passage S 995 - Lifespan Respite Care Reauthorization Act: Support passage S 1202 - Independence At Home Act: support passage HR2408 - Ensuring Access to Complex Rehabilitation Technology Act of 2019: support passage HR 748, CARES Act: Asked that occupational therapy practitioners and other therapy providers be made eligible to provide Medicare telehealth services under emergency waivers. CMS - Met with Gift Tee, Director of the Division of Practitioner Services; Kathy Bryant; and Pam West: Discussed Medicare Part B payment reductions to therapy provider payments proposed for the 2021 physician fee schedule. We discussed proposals that would allow the changes to evaluation and management (E&M) codes to proceed without adversely affecting specialties that do not bill E&M codes. HR 6365/3559 -Immediate Relief for Rural Facilities and Providers Act of 2020: Support passage.

Client expense: $190,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Issues relating to Medicare's coverage of lymphedema treatment and the Lymphedema Treatment Act (S. 518/H.R. 1948). H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act H.R. 6201 - Families First Coronavirus Response Act H.R. 748 - Coronavirus Aid, Relief, and Economic Security (CARES) Act

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues relating to Medicare's coverage of lymphedema treatment and the Lymphedema Treatment Act (S. 518/H.R. 1948). H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act H.R. 6201 - Families First Coronavirus Response Act H.R. 748 - Coronavirus Aid, Relief, and Economic Security (CARES) Act

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Prevention Initiatives for Fraud and Abuse in the Medicare program Electronic health records/health information technology incentives for Physical Therapists NCCI Edits Protection of programs related to physical therapy in deficit reduction Medicare Advantage Health Information Technology Essential Health Benefits Medicare improvement standards Medicare appeals process Inclusion of physical therapists in quality programs Medicare Self-referral Coverage of telehealth APTA Registry/QCDR measures Medicare Quality Programs Accelerating Innovation in Medicine Act (AIM) IMPACT Act Chronic Care Management Orthotics and Prosthetics Medicare Private Contracting SNF 3-Day rule PT Outcomes Registry Administrative Burden PTA Differential in Medicare Prior Authorization in Medicare Advantage Plans Alternative payment models Certified EHR technology DMEPOS competitive bidding Medicare enrollment Skilled Nursing Facility payment Home Health payment Medical review (Medicare) Technical expert panel nominations Reducing Health Care costs REAADI & DRMA Acts S. 433 Home Health Payment Innovation Act of 2019 HR 3107 Improving Seniors Timely Access to Care Act of 2019 HR 1948/S. 518 Lymphedema Treatment Act of 2019 Improving Access to Medicare Coverage Act of 2019 (HR 7682/S 753) Critical Access Hospital Relief Act of 2019 (HR 1041/S 586) Medicare Opt-Out Home Health Payment Innovation Act (S 433) HR 4932/S 2741 CONNECT for Health Act of 2019 Medicare Fee Schedule HR 5693 Primary Health Services Enhancement Act

Client expense: $271,987 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Social Security Administration (SSA), Veterans Affairs, Dept of (VA), White House Office

Monitoring healthcare regulations and legislation; Palliative Care Hospice Education & Treatment Act PCHETA (H.R 647/S 2080); Cancer Drug Parity Act (H.R. 1730/S. 741); Lymphedema Treatment Act (H.R. 1948/S. 518); Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act";

Client expense: $80,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, White House Office

S.518/H.R.1948, Lymphedema Treatment Act

Client expense: $1,860,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Highway Traffic Safety Administration (NHTSA), Patent & Trademark Office (PTO), Pipeline & Hazardous Materials Safety Administration, SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

S.692 / H.R. 2207, Protect Medical Innovation Act of 2019 S.518 / H.R.1948, Lymphedema Treatment Act S. 1895, Lower Health Care Costs Act

Client expense: $1,860,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Highway Traffic Safety Administration (NHTSA), Patent & Trademark Office (PTO), Pipeline & Hazardous Materials Safety Administration, SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

H.R. 4932, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019, all provisions S. 2741, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019, all provisions H.R. 3414, Opioid Workforce Act of 2019, all provisions S. 2892, Opioid Workforce Act of 2019, all provisions H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act, provisions relating to drug pricing transparency, incorporating value into drug pricing, reducing prior authorization burdens, physician samples H.R. 3107, Improving Seniors' Timely Access to Care Act of 2019, all provisions H.R. 1948, Lymphedema Treatment Act of 2019, all provisions S. 518, Lymphedema Treatment Act of 2019, all provisions H.R. 1570, Removing Barriers to Colorectal Cancer Screening Act of 2019, all provisions S. 668, Removing Barriers to Colorectal Cancer Screening Act of 2019, all provisions H.R. 1329, Medicaid Reentry Act, all provisions S. 2648, Rural ACO Improvement Act, all provisions H.R. 19, Lower Costs, More Cures Act of 2019, all provisions S. 348, Resident Physician Shortage Reduction Act of 2019, all provisions Medicare program: Protecting Access to Medicare Act (PAMA)/lab coding Medicare program: Medicare Care Coordination Improvement Act Medicare program: Protecting and Improving Medicare for our Nations Seniors, Section 5 Medicare program: Appropriate Use Criteria (AUC) G-Codes and modifiers Medicare program: Medicare physician payment update Medicare program: Regulatory relief Medicare program: Medicare for All Medicare program: Stark Law and Anti-Kickback Statute Medicare program: Health IT burdens Medicare program: Merit-based Incentive Payment System (MIPS) Medicare program: Data Privacy Medicare program: Alternative Payment Models (APMs) Medicare program: Accountable Care Organizations (ACOs) Medicare program: Pre-diabetes test coverage Medicare program: Patient Access and Interoperability Medicare program: Prior Authorization Medicare program: Evaluation and Management(E/M) Medicare program: Graduate Medical Education/Cap-Flexibility Medicare program: Pharmacy Benefits Manager (PBM)/Rx drug price transparency Medicare program: Primary Care First/medical oncology, radiation oncology, diabetes prevention Medicare program: Medicare Diabetes Prevention Program Medicare program: Open Payments Medicare program: CMS Provider Compliance & Regulatory Relief Medicare program: PECOS Enrollment/Revalidation Medicare and Medicaid programs: Opioids/medication-assisted treatment Medicare and Medicaid programs: Quality Payment Program Medicare and Medicaid programs: Medicare Access and Chip Reauthorization Act (MACRA) implementation/technical improvements/physician payments Medicaid program: Idaho Medicaid Reform Waiver Medicaid program: Funding and maternal mortality

Client expense: $3,950,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Drug Enforcement Administration (DEA), Federal Bureau of Investigation (FBI), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), President of the U.S., SENATE, State, Dept of (DOS), Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office

S.692 / H.R. 2207 / H.R. 1865, Protect Medical Innovation Act of 2019 S.518 / H.R.1948, Lymphedema Treatment Act S. 1895, Lower Health Care Costs Act

Client expense: $1,740,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Highway Traffic Safety Administration (NHTSA), Patent & Trademark Office (PTO), Pipeline & Hazardous Materials Safety Administration, SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

S.518/H.R.1948, Lymphedema Treatment Act

Client expense: $1,740,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Highway Traffic Safety Administration (NHTSA), Patent & Trademark Office (PTO), Pipeline & Hazardous Materials Safety Administration, SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 1948, Lymphedema Treatment Act; HR 6808, Patient Navigation Assistance Act; HR 1570 and S. 668, the Removing Barriers to Colorectal Cancer Screening Act, and regulatory issues related to the Medicare coinsurance issue in these bills; S.2218 and H.R 4821, the Covering Our FAS Allies (COFA) Act & issues related to Medicaid coverage for Compacts of Free Association (COFA) migrants; CMS-issued regulations pertaining to Medicare Part B reimbursement - the CY2020 Medicare Physician Fee Schedule; HR 913, The CLINICAL TREATMENT Act, Medicaid covering routine care costs for beneficiaries who participate in an approved clinical trial; Issues related to potential Administration guidance relating to giving states the option to block grant their Medicaid program; Issues related to Puerto Ricos Medicaid program, including H.R. 3631, Territories Health Care Improvement Act; H.R. 3, the Lower Drug Prices Now Act - legislation for lowering prescription drug costs, lowering out of pocket expenses for Medicare beneficiaries, and placing a cap on Medicare Part D; S. 2543, the Prescription Drug Pricing Reduction Act of 2019 - legislation for lowering prescription drug costs, lowering out of pocket costs for Medicare beneficiaries, and placing a cap on Medicare Part D; Issues related to Medicaid Non-Emergency Medical Transportation; and S. 2911 - Seniors Prescription Drug Relief Act of 2019, would allow Medicare beneficiaries who reach an out of pocket cap to spread their payments over the course of the entire year.

Client expense: $1,650,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office

No bill: Support inclusion of occupational therapy services via telehealth under Medicare Part B, Medicare Advantage and any demonstration programs such as telehealth within accountable care organizations. HR 3127/S 1725 - The Home Health Flexibility Act: Support the ability of occupational therapists to conduct the initial and comprehensive assessments for Medicare Home Health cases. S 518/HR 1948 - Lymphedema Treatment Act - Support passage. No bill: Advocate for Congressional oversight of new Medicare payment models - PDPM & PDGM. No bill: Support for Congressional attention to the issue of falls related injuries and falls prevention. No bill: Advocate to obtain signatures on letter to CMS regarding proposed cuts to therapy services in the Physician Fee Schedule Proposed Rule. HR 4932/S 2741 - CONNECT for Health Act of 2019: Support expanded coverage for services provided to Medicare patients via telehealth, including occupational therapy and other therapy services. HR 1329 - Medicaid Reentry Act (mental health and Medicaid policy): Support passage S 1754/HR 3215 - The Disaster Relief Medicaid Act (DRMA): Support passage No bill: Support for Medicare payment for evidence-based programs, led by occupational therapists, that support caregivers for people with dementia. No bill: Support for Medicare payment for evidence-based programs, led by occupational therapists, to support aging in place. HR 1109 - Mental Health Services for Students Act: Support passage HR 4564 - Suicide Prevention Lifeline Improvement Act: Support passage HR 1767 - Excellence in Mental Health and Addiction Treatment Expansion Act: Support passage HR 4861 - Effective Suicide Screening and Assessment in the Emergency Department Act: Support passage HR 4309 - Barriers to Suicide Act: Support passage S 995 - Lifespan Respite Care Reauthorization Act: Support passage

Client expense: $180,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues relating to Medicare's coverage of lymphedema treatment and the Lymphedema Treatment Act (S. 518/H.R. 1948). H.R. 1865 - Further Consolidated Appropriations Act, 2020 H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues relating to Medicare's coverage of lymphedema treatment and the Lymphedema Treatment Act (S. 518/H.R. 1948). H.R. 1865 - Further Consolidated Appropriations Act, 2020 H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 518/H.R. 1948 - Lymphedema Treatment Act of 2019 S. 1037/H.R. 2788 - Rural Health Clinic Modernization Act of 2019 S. 296/H.R. 2150 - Home Health Care Planning Improvement Act S. 237/H.R. 808 - Promoting Access to Diabetic Shoes Act H.R. 900 - ACO Assignment Improvement Act of 2019 S. 1399/H.R. 728 - Title VIII Nursing Workforce Reauthorization Act of 2019 S. 2842/H.R. 3911 - Increasing Access to Quality Cardiac Rehabilitation Care Act of 2019 S. 1895 - Lower Health Care Costs Act H.R. 3107 - Improving Seniors' Timely Access to Care Act of 2019 H.R. 3630 - No Surprises Act H.R. 3925 - Reducing Barriers to Substance Use Treatment Act S.2074/H.R. 2482 - Mainstreaming Addiction Treatment Act of 2019 H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act H.R. 4974 - Medication Access and Training Expansion Act of 2019 Executive Order 13890 - Protecting and Improving Medicare for Our Nation's Seniors S. 2741/H.R. 4932 - Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019 S. 2971 - CAPTA Reauthorization Act of 2019 H.R. 19 - Lower Costs, More Cures Act of 2019 S. 2543 - Prescription Drug Pricing Reduction Act of 2019 H.R. 647 - Palliative Care and Hospice Education and Training Act Reducing Regulatory Burdens Medication-Assisted Therapies (MATs) Opioid Abuse Epidemic Documentation of medical records Rural Health Issues Provider Non-Discrimination

Client expense: $223,105 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Veterans Affairs, Dept of (VA), White House Office

Monitoring healthcare regulations and legislation; Palliative Care Hospice Education & Treatment Act PCHETA (H.R 647/S 2080); Cancer Drug Parity Act (H.R. 1730/S. 741); Lymphedema Treatment Act (H.R. 1948/S. 518); Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act";

Client expense: $301,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE

Prevention Initiatives for Fraud and Abuse in the Medicare program Electronic health records/health information technology incentives for Physical Therapists NCCI Edits Protection of programs related to physical therapy in deficit reduction Medicare Advantage Health Information Technology Essential Health Benefits Medicare improvement standards Medicare appeals process Inclusion of physical therapists in quality programs Medicare Self-referral Coverage of telehealth APTA Registry/QCDR measures Medicare Quality Programs Accelerating Innovation in Medicine Act (AIM) IMPACT Act Chronic Care Management Orthotics and Prosthetics Medicare Private Contracting SNF 3-Day rule PT Outcomes Registry Administrative Burden PTA Differential in Medicare Prior Authorization in Medicare Advantage Plans Alternative payment models Certified EHR technology DMEPOS competitive bidding Medicare enrollment Skilled Nursing Facility payment Home Health payment Medical review (Medicare) Technical expert panel nominations Reducing Health Care costs REAADI & DRMA Acts S. 433 Home Health Payment Innovation Act of 2019 HR 3107 Improving Seniors Timely Access to Care Act of 2019 HR 1948/S. 518 Lymphedema Treatment Act of 2019 Improving Access to Medicare Coverage Act of 2019 (HR 7682/S 753) Critical Access Hospital Relief Act of 2019 (HR 1041/S 586) Medicare Opt-Out Home Health Payment Innovation Act (S 433)

Client expense: $262,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Social Security Administration (SSA), Veterans Affairs, Dept of (VA), White House Office

Monitored the introduction of drug pricing legislation (HR 3) for its potential impact on existing and emerging cancer drug therapies and site neutrality. Monitored Medicare reimbursement developments in the agencies and Congress for alternative cancer therapies such as CAR-T. Reviewed HR 3235, Access to Genetic Counselor Services Act and HR 1948, Lymphedema Treatment Act for potential support.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Monitored the introduction of drug pricing legislation (HR 3) for its potential impact on existing and emerging cancer drug therapies and site neutrality. Monitored Medicare reimbursement developments in the agencies and Congress for alternative cancer therapies, such as CAR-T. Reviewed HR 1948, Lymphedema Treatment Act and HR 3235, Access to Genetic Counselor Services Act for potential support.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.518/H.R.1948, Lymphedema Treatment Act

Client expense: $1,740,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Highway Traffic Safety Administration (NHTSA), Patent & Trademark Office (PTO), Pipeline & Hazardous Materials Safety Administration, SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

S.692 / H.R. 2207, Protect Medical Innovation Act of 2019 S.518 / H.R.1948, Lymphedema Treatment Act S. 1895, Lower Health Care Costs Act

Client expense: $1,740,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Highway Traffic Safety Administration (NHTSA), Patent & Trademark Office (PTO), Pipeline & Hazardous Materials Safety Administration, SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office